PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy

To develop and validate the predictive warfarin dosing algorithm.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Valve Diseases Cardiovascular Diseases Heart Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Inje University

Busan, 614-735, South Korea

About this study

This study aims to develop and validate the predictive warfarin dosing algorithm for personalized warfarin pharmacotherapy in Korean patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

the patients taking warfarin

Exclusion criteria

noncompliance

Treatment and study plan

Primary outcomes

To Develop and Validate the Predictive Warfarin Dosing Algorithm

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Inje University

Other

Registry information

Official study title

Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy in Korean Patients

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: Aug 10, 2010
Registry last updated: Jun 3, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed